IBDEI1X4 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30637,1,4,0)
 ;;=4^I31.9
 ;;^UTILITY(U,$J,358.3,30637,2)
 ;;=^5007165
 ;;^UTILITY(U,$J,358.3,30638,0)
 ;;=I49.9^^123^1579^2
 ;;^UTILITY(U,$J,358.3,30638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30638,1,3,0)
 ;;=3^Arrhythmia,Cardiac,Unspec
 ;;^UTILITY(U,$J,358.3,30638,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,30638,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,30639,0)
 ;;=I13.0^^123^1579^9
 ;;^UTILITY(U,$J,358.3,30639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30639,1,3,0)
 ;;=3^HTN Hrt Disease w/ Hrt Failure and CKD,Stage 1-4
 ;;^UTILITY(U,$J,358.3,30639,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,30639,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,30640,0)
 ;;=I13.2^^123^1579^10
 ;;^UTILITY(U,$J,358.3,30640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30640,1,3,0)
 ;;=3^HTN Hrt Disease w/ Hrt Failure and CKD, Stage 5 or ESRD
 ;;^UTILITY(U,$J,358.3,30640,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,30640,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,30641,0)
 ;;=I13.10^^123^1579^11
 ;;^UTILITY(U,$J,358.3,30641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30641,1,3,0)
 ;;=3^HTN Hrt Disease w/o Hrt Failure and CKD, Stage 1-4
 ;;^UTILITY(U,$J,358.3,30641,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,30641,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,30642,0)
 ;;=I13.11^^123^1579^12
 ;;^UTILITY(U,$J,358.3,30642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30642,1,3,0)
 ;;=3^HTN Hrt Disease w/o Hrt Failure and CKD,Stage 5 or ESRD
 ;;^UTILITY(U,$J,358.3,30642,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,30642,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,30643,0)
 ;;=I50.1^^123^1579^15
 ;;^UTILITY(U,$J,358.3,30643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30643,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,30643,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,30643,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,30644,0)
 ;;=E21.3^^123^1580^17
 ;;^UTILITY(U,$J,358.3,30644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30644,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,30644,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,30644,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,30645,0)
 ;;=E78.5^^123^1580^16
 ;;^UTILITY(U,$J,358.3,30645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30645,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,30645,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,30645,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,30646,0)
 ;;=M10.30^^123^1580^11
 ;;^UTILITY(U,$J,358.3,30646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30646,1,3,0)
 ;;=3^Gout d/t Renal Impairment,Unspec Site
 ;;^UTILITY(U,$J,358.3,30646,1,4,0)
 ;;=4^M10.30
 ;;^UTILITY(U,$J,358.3,30646,2)
 ;;=^5010356
 ;;^UTILITY(U,$J,358.3,30647,0)
 ;;=E66.9^^123^1580^33
 ;;^UTILITY(U,$J,358.3,30647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30647,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,30647,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,30647,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,30648,0)
 ;;=E66.01^^123^1580^32
 ;;^UTILITY(U,$J,358.3,30648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30648,1,3,0)
 ;;=3^Obesity,Morbid,d/t Excess Calories
 ;;^UTILITY(U,$J,358.3,30648,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,30648,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,30649,0)
 ;;=D50.9^^123^1580^2
 ;;^UTILITY(U,$J,358.3,30649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30649,1,3,0)
 ;;=3^Anemia,Iron Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,30649,1,4,0)
 ;;=4^D50.9
